tobramycin has been researched along with Body Weight in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (50.00) | 18.7374 |
| 1990's | 10 (25.00) | 18.2507 |
| 2000's | 4 (10.00) | 29.6817 |
| 2010's | 5 (12.50) | 24.3611 |
| 2020's | 1 (2.50) | 2.80 |
| Authors | Studies |
|---|---|
| Lashev, LD; Marinkov, TN; Pashov, DA | 1 |
| Diakov, L; Pashov, D; Vangelov, S | 1 |
| Andreotis, J; Cracknell, VC; Facibeni, G; Owais, E; Pradella, G | 1 |
| Diakov, L; Lashev, L; Pashov, D | 1 |
| Cloutier, I; El Hassani, M; Koloskoff, K; Marsot, A; Matouk, E; Pilote, S; Simard, C; Thirion, DJG | 1 |
| Brüggemann, RJM; Knibbe, CAJ; Mouton, JW; Smit, C; van Dongen, HPA; Wasmann, RE; Wiezer, MJ | 1 |
| Alghanem, SS; Thomson, AH; Touw, DJ | 1 |
| Alghanem, S; Paterson, I; Thomson, AH; Touw, DJ | 1 |
| Alipour, M; Lui, EM; Omri, A; Suntres, ZE | 1 |
| Allegaert, K; Brussee, JM; Danhof, M; De Cock, RF; de Hoog, M; Knibbe, CA; Mulla, H; Sherwin, CM; van den Anker, JN | 1 |
| Borras-Blasco, J; Gonzalez-Delgado, M; Peris-Marti, JF; Rosique-Robles, JD | 1 |
| Holford, N; Kirkpatrick, C; Matthews, I | 1 |
| Hennig, S; Kirkpatrick, CM; Norris, R | 1 |
| Abel, SR; Aronoff, GR | 1 |
| Bickers, RG; Glazer, JP; Gregoire, RP; McClead, RE; Menke, JA; Nahata, MC; Powell, DA | 1 |
| Fan, L; Kelly, HB; Menendez, R; Murphy, S | 1 |
| Blair, AD; Counts, GW; Turck, M; Wagner, KF | 1 |
| Arpini, A; Bamonte, F; Marzanatti, M; Ongini, E; Parravicini, L | 1 |
| Clayman, AE; Miller, PB; Stein, GE; Vakoutis, J | 1 |
| Kitamura, N; Kobayashi, Y; Kojima, T; Ono, A; Sasai-Takedatsu, M; Taketani, S | 1 |
| Bakker, W; Heijerman, HG; Hermans, J; Touw, DJ; Vinks, AA | 1 |
| Beauchamp, D; Bergeron, MG; Bergeron, Y; Grenier, L; Labrecque, G; Lin, L; Simard, M | 1 |
| Wasfi, IA | 1 |
| Bakker, W; Heijerman, HG; Touw, DJ; Vinks, AA | 1 |
| Buckler, V; Bush, PW; Kale-Pradhan, PB | 1 |
| Dortant, PM; Peters-Volleberg, GW; Speijers, GJ | 1 |
| Barletta, JF; Erstad, BL; Johnson, SB; Nix, DE; Nix, LC | 1 |
| Bratlid, D; Fuglesang, JE | 1 |
| Belova, IP; Filippos'iants, ST; Gol'dberg, LE; Shepelevtseva, NG; Vertogradova, TP | 1 |
| Bowman, RL; Kaloyanides, GJ; Pastoriza-Munoz, E; Soberon, L | 1 |
| Ho, M; Lyon, JA; Pasculle, AW; Pazin, GJ; Schwartz, SN | 1 |
| Bertino, JS; Etzel, JV; Nafziger, AN | 1 |
| Heuson-Stiennon, JA; Laurent, G; Nonclercq, D; Toubeau, G; Tulkens, P | 1 |
| Aran, JM; Aurousseau, C; Cazals, Y; Erre, JP | 1 |
| Crane, LR; Duman, K; Hatfield, SM; Karanes, C; Kiel, RJ | 1 |
| Bregman, CL; Williams, PD | 1 |
| Job, ML; Murphy, JE; Peltier, TT; Tointon, MM; Ward, ES | 1 |
| Armstrong, DK; Dasta, JF | 1 |
| Gilbert, DN; Houghton, DC; Kohlhepp, SJ; Kohnen, PW; Wood, CA | 1 |
| Degener, JE; Driessen, O; Dzoljic-Danilovic, G; Hermans, J; Horrevorts, AM; Kerrebijn, KF; Michel, MF | 1 |
1 trial(s) available for tobramycin and Body Weight
| Article | Year |
|---|---|
An evaluation of apramycin soluble powder for the treatment of naturally acquired Escherichia coli infections in broilers.
Topics: Animals; Anti-Bacterial Agents; Body Weight; Chickens; Clinical Trials as Topic; Escherichia coli Infections; Nebramycin; Poultry Diseases | 1986 |
39 other study(ies) available for tobramycin and Body Weight
| Article | Year |
|---|---|
Interspecies differences in the pharmacokinetics of kanamycin and apramycin.
Topics: Animals; Body Weight; Chickens; Columbidae; Female; Goats; Half-Life; Injections, Intravenous; Kanamycin; Male; Models, Statistical; Nebramycin; Rabbits; Sheep; Species Specificity | 1992 |
[Chronic 90-day toxicity of apramycin in chickens].
Topics: Animals; Anti-Bacterial Agents; Blood Cells; Body Weight; Chickens; Dose-Response Relationship, Drug; Female; Male; Nebramycin; Time Factors | 1987 |
[Subchronic toxicity of apramycin in pigs].
Topics: Animals; Anti-Bacterial Agents; Blood Cell Count; Body Weight; Chronic Disease; Dose-Response Relationship, Drug; Female; Hemoglobins; Male; Nebramycin; Swine; Swine Diseases; Time Factors | 1987 |
Development and Evaluation of a Height-Based Tobramycin Initial Dosing Nomogram for the Treatment of Adult Cystic Fibrosis Pulmonary Exacerbations.
Topics: Adult; Anti-Bacterial Agents; Body Weight; Cystic Fibrosis; Humans; Nomograms; Tobramycin | 2023 |
Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Non-obese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study.
Topics: Adult; Anti-Bacterial Agents; Bariatric Surgery; Body Weight; Computer Simulation; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged; Obesity, Morbid; Prospective Studies; Tobramycin | 2019 |
Pharmacokinetic/pharmacodynamic analysis of weight- and height-scaled tobramycin dosage regimens for patients with cystic fibrosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Height; Body Weight; Cystic Fibrosis; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Plasma; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Young Adult | 2019 |
Influence of multiple courses of therapy on aminoglycoside clearance in adult patients with cystic fibrosis.
Topics: Adolescent; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Body Height; Body Weight; Cystic Fibrosis; Female; Fluorescence Polarization Immunoassay; Gentamicins; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Statistical; Reproducibility of Results; Tobramycin; Young Adult | 2013 |
Co-administration of aqueous ginseng extract with tobramycin stimulates the pro-inflammatory response and promotes the killing of Pseudomonas aeruginosa in the lungs of infected rats.
Topics: Agar; Animals; Anti-Bacterial Agents; Bacterial Load; Body Weight; Chemokines; Culture Media; Cytokines; Inflammation; Lung; Lung Diseases; Male; Organ Size; Panax; Plant Extracts; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Tobramycin | 2013 |
Simultaneous pharmacokinetic modeling of gentamicin, tobramycin and vancomycin clearance from neonates to adults: towards a semi-physiological function for maturation in glomerular filtration.
Topics: Adolescent; Adult; Aging; Body Weight; Child; Child, Preschool; Creatinine; Gentamicins; Glomerular Filtration Rate; Humans; Infant; Infant, Newborn; Metabolic Clearance Rate; Models, Biological; Tobramycin; Vancomycin | 2014 |
Evaluation of once daily tobramycin dosing in critically ill patients through Bayesian simulation.
Topics: Anti-Bacterial Agents; Bayes Theorem; Body Weight; Critical Illness; Drug Administration Schedule; Hospital Bed Capacity, 300 to 499; Hospitals, University; Humans; Injections, Intravenous; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Tobramycin | 2004 |
Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides.
Topics: Adult; Aged; Aging; Aminoglycosides; Anti-Bacterial Agents; Body Weight; Creatinine; Female; Gentamicins; Humans; Kidney; Male; Middle Aged; Models, Chemical; Predictive Value of Tests; Tobramycin | 2004 |
Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis--a population pharmacokinetic study.
Topics: Adolescent; Anti-Bacterial Agents; Body Weight; Child; Child, Preschool; Cystic Fibrosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infant; Injections, Intravenous; Male; Models, Chemical; Predictive Value of Tests; Retrospective Studies; Tobramycin; Treatment Outcome | 2008 |
Evaluation of a microcomputer program for predicting tobramycin serum concentrations.
Topics: Adolescent; Adult; Aged; Body Height; Body Weight; Computers; Creatinine; Female; Humans; Kinetics; Male; Microcomputers; Middle Aged; Sex Factors; Software; Tobramycin | 1984 |
Tobramycin kinetics in newborn infants.
Topics: Anti-Bacterial Agents; Bacterial Infections; Body Weight; Female; Half-Life; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infusions, Parenteral; Kidney; Kinetics; Male; Metabolic Clearance Rate; Tobramycin | 1983 |
Pharmacokinetics of tobramycin in cystic fibrosis.
Topics: Adolescent; Adult; Aminoglycosides; Anti-Bacterial Agents; Biopharmaceutics; Body Surface Area; Body Weight; Child; Child, Preschool; Creatinine; Cystic Fibrosis; Female; Humans; Lung Diseases; Male; Pseudomonas Infections; Tobramycin | 1982 |
Gentamicin and tobramycin Kinetics.
Topics: Adult; Aged; Anti-Bacterial Agents; Body Weight; Female; Gentamicins; Humans; Injections, Intravenous; Kinetics; Male; Middle Aged; Tobramycin | 1982 |
Comparative ototoxicity of amikacin, gentamicin, netilmicin, and tobramycin in guinea pigs.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Body Weight; Cochlea; Ear Diseases; Electrophysiology; Female; Gentamicins; Guinea Pigs; Hearing Disorders; Male; Netilmicin; Tobramycin | 1982 |
Aminoglycoside monitoring program.
Topics: Aminoglycosides; Anti-Bacterial Agents; Body Weight; Gentamicins; Humans; Kinetics; Tobramycin | 1981 |
Urinary trehalase activity is a useful marker of renal proximal tubular damage in newborn infants.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Biomarkers; Body Weight; Cell Division; Creatinine; Female; Gestational Age; Humans; Infant, Newborn; Kidney Tubules, Proximal; Male; Penicillins; Tobramycin; Trehalase | 1995 |
Suggestions for the optimization of the initial tobramycin dose in adolescent and adult patients with cystic fibrosis.
Topics: Adolescent; Adult; Body Weight; Cystic Fibrosis; Dose-Response Relationship, Drug; Female; Humans; Male; Mathematics; Pseudomonas Infections; Regression Analysis; Respiratory Tract Infections; Retrospective Studies; Tobramycin | 1994 |
Temporal changes of pharmacokinetics, nephrotoxicity, and subcellular distribution of tobramycin in rats.
Topics: Acetylglucosamine; Acetylglucosaminidase; Animals; Body Weight; Female; Immunohistochemistry; Kidney Cortex; Kidney Diseases; Rats; Rats, Sprague-Dawley; Subcellular Fractions; Thymidine; Time Factors; Tobramycin | 1994 |
The effect of endotoxin on tobramycin pharmacokinetics in young and aged rats.
Topics: Aging; Animals; Body Weight; Endotoxins; Escherichia coli; Half-Life; Injections, Intraperitoneal; Male; Rats; Rats, Wistar; Tobramycin | 1993 |
Prospective evaluation of a dose prediction algorithm for intravenous tobramycin in adolescent and adult patients with cystic fibrosis.
Topics: Adolescent; Adult; Algorithms; Anti-Bacterial Agents; Body Weight; Cystic Fibrosis; Female; Humans; Injections, Intravenous; Male; Middle Aged; Prospective Studies; Tobramycin | 1996 |
Effect of body weight on aminoglycoside pharmacokinetics in patients with hypoalbuminemia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Biological Availability; Body Weight; Female; Gentamicins; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Retrospective Studies; Serum Albumin; Tobramycin | 1997 |
Comparison of tobramycin nephrotoxicity in young adult and aged female rats.
Topics: Age Factors; Animals; Anti-Bacterial Agents; Body Weight; Eating; Female; Kidney; Organ Size; Rats; Tobramycin | 1999 |
Population pharmacokinetics of aminoglycosides in critically ill trauma patients on once-daily regimens.
Topics: Adolescent; Adult; Age Factors; Aged; Anti-Bacterial Agents; Body Weight; Creatinine; Critical Illness; Drug Administration Schedule; Drug Monitoring; Gentamicins; Humans; Metabolic Clearance Rate; Middle Aged; Multiple Trauma; Nonlinear Dynamics; Prospective Studies; Time Factors; Tissue Distribution; Tobramycin | 2000 |
Clinical pharmacology of tobramycin in infants.
Topics: Anti-Bacterial Agents; Bacterial Infections; Body Weight; Child, Preschool; Drug Evaluation; Half-Life; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases; Tobramycin | 1979 |
[Toxicity of tobramycin in single and multiple administrations to laboratory animals].
Topics: Animals; Anti-Bacterial Agents; Blood; Body Weight; Dogs; Dose-Response Relationship, Drug; Female; Guinea Pigs; Kidney; Lethal Dose 50; Liver; Male; Mice; Organ Size; Rats; Time Factors; Tobramycin | 1979 |
Comparative nephrotoxicities of gentamicin, netilmicin and tobramycin in the rat.
Topics: Animals; Anti-Bacterial Agents; Blood Urea Nitrogen; Body Weight; Creatinine; Gentamicins; Kidney; Kidney Diseases; Kidney Tubules; Netilmicin; Rats; Tobramycin; Water-Electrolyte Balance | 1979 |
A controlled investigation of the pharmacokinetics of gentamicin and tobramycin in obese subjects.
Topics: Anti-Bacterial Agents; Body Weight; Gentamicins; Humans; Kinetics; Obesity; Tobramycin | 1978 |
Variation in the pharmacokinetics of gentamicin and tobramycin in patients with pleural effusions and hypoalbuminemia.
Topics: Aged; Aging; Body Weight; Female; Fluorescence Polarization Immunoassay; Gentamicins; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Pleural Effusion; Prospective Studies; Regression Analysis; Serum Albumin; Tobramycin | 1992 |
Renal tissue injury and proliferative response after successive treatments with anticancer platinum derivatives and tobramycin.
Topics: Animals; Body Weight; Carboplatin; Cell Division; Cisplatin; DNA; Drug Administration Schedule; Drug Interactions; Female; Kidney Tubular Necrosis, Acute; Lysosomes; Phospholipids; Rats; Rats, Inbred Strains; Tobramycin | 1990 |
Ototoxicity of teicoplanin in the guinea pig.
Topics: Animals; Body Weight; Electronystagmography; Evoked Potentials, Auditory; Female; Glycopeptides; Guinea Pigs; Hair Cells, Auditory; Male; Teicoplanin; Tobramycin; Vestibule, Labyrinth | 1987 |
Miconazole-induced alteration in tobramycin pharmacokinetics.
Topics: Adult; Body Weight; Bone Marrow Transplantation; Cholesterol; Drug Interactions; Female; Humans; Kinetics; Male; Miconazole; Middle Aged; Mycoses; Neutropenia; Time Factors; Tobramycin; Triglycerides; Vancomycin | 1986 |
Comparative nephrotoxicity of carboplatin and cisplatin in combination with tobramycin.
Topics: Animals; Antineoplastic Agents; Body Weight; Carboplatin; Cisplatin; Drug Synergism; Drug Therapy, Combination; Fibrosis; Kidney; Male; Organoplatinum Compounds; Rats; Rats, Inbred Strains; Tobramycin | 1986 |
Alterations in aminoglycoside volume of distribution in patients below ideal body weight.
Topics: Adult; Aged; Amikacin; Body Weight; Female; Gentamicins; Humans; Male; Middle Aged; Retrospective Studies; Tobramycin | 1987 |
More on variability in aminoglycoside volume of distribution.
Topics: Adult; Aged; Amikacin; Body Weight; Critical Care; Gentamicins; Humans; Middle Aged; Surgical Procedures, Operative; Tobramycin | 1987 |
Vancomycin enhancement of experimental tobramycin nephrotoxicity.
Topics: Animals; Blood Urea Nitrogen; Body Weight; Creatinine; Drug Synergism; Kidney; Kidney Diseases; Male; Rats; Rats, Inbred F344; Tobramycin; Vancomycin | 1986 |
Pharmacokinetics of tobramycin in patients with cystic fibrosis. Implications for the dosing interval.
Topics: Adolescent; Adult; Age Factors; Body Weight; Child; Chronic Disease; Cystic Fibrosis; Female; Half-Life; Humans; Kinetics; Male; Pseudomonas Infections; Respiratory Tract Infections; Time Factors; Tobramycin | 1985 |